Schlumberger Limited. (SLB) EPS Estimated At $0.30; Amphastar Pharmaceuticals (AMPH) Covered By 4 Bulls

June 29, 2017 - By Adrian Erickson

Among 5 analysts covering Amphastar Pharmaceuticals (NASDAQ:AMPH), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Amphastar Pharmaceuticals had 9 analyst reports since August 10, 2015 according to SRatingsIntel. Jefferies maintained Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) rating on Tuesday, August 9. Jefferies has “Buy” rating and $19 target. BMO Capital Markets initiated Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) on Wednesday, June 29 with “Market Perform” rating. The stock of Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) has “Outperform” rating given on Friday, February 19 by Wells Fargo. As per Tuesday, August 18, the company rating was upgraded by Zacks. The firm has “Buy” rating by Zacks given on Monday, August 10. Jefferies maintained it with “Buy” rating and $17 target in Tuesday, January 19 report. Needham maintained the stock with “Buy” rating in Tuesday, May 10 report. The firm has “Outperform” rating given on Tuesday, March 14 by Raymond James. See Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) latest ratings:

14/03/2017 Broker: Raymond James Old Rating: Strong Buy New Rating: Outperform Old Target: $21.00 New Target: $18.00 Downgrade

Analysts expect Schlumberger Limited. (NYSE:SLB) to report $0.30 EPS on July, 20.They anticipate $0.07 EPS change or 30.43% from last quarter’s $0.23 EPS. SLB’s profit would be $413.47M giving it 54.38 P/E if the $0.30 EPS is correct. After having $0.25 EPS previously, Schlumberger Limited.’s analysts see 20.00% EPS growth. The stock decreased 0.23% or $0.15 during the last trading session, reaching $65.25. About shares traded. Schlumberger Limited. (NYSE:SLB) has declined 3.30% since June 29, 2016 and is downtrending. It has underperformed by 20.00% the S&P500.

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company has market cap of $786.77 million. The Firm focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. It has a 92.94 P/E ratio. The Firm has two divisions: finished pharmaceutical products and active pharmaceutical ingredients products.

The stock increased 2.43% or $0.42 during the last trading session, reaching $17.68. About shares traded. Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) has risen 8.19% since June 29, 2016 and is uptrending. It has underperformed by 8.51% the S&P500.

Investors sentiment decreased to 1.32 in 2016 Q4. Its down 1.85, from 3.17 in 2016Q3. It dived, as 15 investors sold Amphastar Pharmaceuticals Inc shares while 41 reduced holdings. 25 funds opened positions while 49 raised stakes. 21.78 million shares or 49.43% less from 43.07 million shares in 2016Q3 were reported. Thrivent Fin For Lutherans holds 19,440 shares. Capstone Asset Mngmt Communications has 0.01% invested in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH). Metropolitan Life Insurance Ny holds 0% of its portfolio in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) for 26,305 shares. Cornerstone Cap Mgmt Llc invested in 0.05% or 354,119 shares. Oberweis Asset Management Inc, a Illinois-based fund reported 27,200 shares. Northern Tru owns 449,463 shares. Mason Street Limited Liability reported 0% in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH). 26,131 are owned by Amer Interest Group. Rhumbline Advisers owns 47,074 shares or 0% of their US portfolio. Voya Invest Mngmt Limited Com holds 0% of its portfolio in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) for 48,160 shares. Ubs Asset Mgmt Americas Inc holds 0% or 138,775 shares in its portfolio. Moreover, Pub Sector Pension Investment Board has 0% invested in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH). 350,270 were accumulated by Prudential Financial. Royal Financial Bank Of Canada has invested 0% of its portfolio in Amphastar Pharmaceuticals Inc (NASDAQ:AMPH). Bancorp Of Ny Mellon Corporation holds 466,588 shares.

Schlumberger N.V. provides technology for reservoir characterization, drilling, production and processing to the gas and oil industry. The company has market cap of $89.93 billion. The Company’s divisions include Reservoir Characterization Group, Drilling Group, Production Group and Cameron Group. It currently has negative earnings. The Reservoir Characterization Group consists of the principal technologies involved in finding and defining hydrocarbon resources.

Investors sentiment decreased to 1.06 in 2016 Q4. Its down 0.03, from 1.09 in 2016Q3. It fall, as 65 investors sold Schlumberger Limited. shares while 567 reduced holdings. 118 funds opened positions while 550 raised stakes. 1.08 billion shares or 1.19% more from 1.07 billion shares in 2016Q3 were reported. Hoplite Mngmt Limited Partnership owns 596,708 shares. 106,182 were accumulated by Connors Investor Svcs Inc. 70,950 are held by Cohen Capital Mngmt Incorporated. Integrated Wealth Counsel Lc invested in 2,084 shares or 0.38% of the stock. Fort Washington Investment Advsrs Oh has 887,700 shares for 1.24% of their portfolio. Connecticut-based Point72 Asset Ltd Partnership has invested 0.33% in Schlumberger Limited. (NYSE:SLB). 134,547 were accumulated by Park Natl Oh. Employees Retirement Of Texas invested 0.48% of its portfolio in Schlumberger Limited. (NYSE:SLB). Rhumbline Advisers invested in 2.35 million shares. Trustco Bancorporation Corp N Y has 7,207 shares for 0.59% of their portfolio. Wms Prns Limited Liability, Maryland-based fund reported 7,537 shares. Tiemann Invest Advisors Ltd Liability Com holds 0.29% in Schlumberger Limited. (NYSE:SLB) or 3,538 shares. Capital Guardian Trust Co has 1.07% invested in Schlumberger Limited. (NYSE:SLB). Deprince Race And Zollo reported 665,939 shares. Argent accumulated 71,070 shares.